Cardiotoxicity more common in thioridazine overdose than with other neuroleptics - PubMed

Cardiotoxicity more common in thioridazine overdose than with other neuroleptics

N A Buckley et al. J Toxicol Clin Toxicol. 1995.

Abstract

On the basis of case reports and small non-comparative series it has been suggested that thioridazine has greater cardiotoxicity in overdose. Limited evidence also suggests an increased association with sudden death in therapeutic doses. The aim of our study is to examine the clinical and electrocardiographic features associated with neuroleptic poisoning and compare thioridazine with other neuroleptics. Consecutive adult patients with neuroleptic poisoning presenting to metropolitan hospitals in Newcastle between 1987 and 1993 were studied. The main outcome measures examined were ECG changes (QRS, QT and QTc intervals), arrhythmias, seizures, degree of sedation, heart rate and blood pressure. Two-hundred ninety-nine patients had ingested thioridazine (104), chlorpromazine (69), trifluoperazine (36), pericyazine (35), haloperidol (33), prochlorperazine (18), fluphenazine (8), or other neuroleptics (7). Sixteen patients had ingested more than one neuroleptic and were excluded from comparative analysis. Thioridazine was more likely to cause tachycardia (odds ratio 1.7, 95% CI 1.1-2.9, p = 0.03), a prolonged QT interval (odds ratio 5.2, 95% CI 1.6-17.1, p = 0.006), prolonged QTc > 450 ms1/2 (odds ratio 4.7, 95% CI 2.7-7.9, p = 0.001), a widened QRS (> 100 ms) (odds ratio 3.1, 95% CI 1.5-6.3, p = 0.001) and arrhythmias (odds ratio infinity, 95% CI 2.4- infinity, p = 0.004). There were no significant differences in the odds of coma (odds ratio 0.5 (0.2-1.5)), hypotension (odds ratio 0.9 (0.4-1.9)) or seizures (odds ratio 3.9 (0.3-43.5)). Adjustment for age, sex, dose ingested and co-ingestion of tricyclic antidepressants or lithium had no major effect on the odds ratios observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Comment in

• Thioridazine cardiotoxicity.

  Hale P, Poklis A. Hale P, et al. J Toxicol Clin Toxicol. 1996;34(1):127-30. doi: 10.3109/15563659609020247. J Toxicol Clin Toxicol. 1996. PMID: 8632504 No abstract available.

Similar articles

• Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.

  Berling I, Isbister GK. Berling I, et al. Ann Emerg Med. 2015 Aug;66(2):154-64. doi: 10.1016/j.annemergmed.2014.12.005. Epub 2015 Jan 30. Ann Emerg Med. 2015. PMID: 25639523

• The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose.

  Buckley NA, Chevalier S, Leditschke IA, O'Connell DL, Leitch J, Pond SM. Buckley NA, et al. Crit Care. 2003 Oct;7(5):R101-7. doi: 10.1186/cc2345. Epub 2003 Aug 18. Crit Care. 2003. PMID: 12974977 Free PMC article.

• Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning.

  Strachan EM, Kelly CA, Bateman DN. Strachan EM, et al. Eur J Clin Pharmacol. 2004 Oct;60(8):541-5. doi: 10.1007/s00228-004-0811-7. Epub 2004 Sep 15. Eur J Clin Pharmacol. 2004. PMID: 15372128

• Thioridazine for schizophrenia.

  Sultana A, Reilly J, Fenton M. Sultana A, et al. Cochrane Database Syst Rev. 2000;(3):CD001944. doi: 10.1002/14651858.CD001944. Cochrane Database Syst Rev. 2000. PMID: 10908517 Updated. Review.

• Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

  Haddad PM, Anderson IM. Haddad PM, et al. Drugs. 2002;62(11):1649-71. doi: 10.2165/00003495-200262110-00006. Drugs. 2002. PMID: 12109926 Review.

Cited by

• Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

  Pacher P, Kecskemeti V. Pacher P, et al. Curr Pharm Des. 2004;10(20):2463-75. doi: 10.2174/1381612043383872. Curr Pharm Des. 2004. PMID: 15320756 Free PMC article. Review.

• Thioridazine for schizophrenia.

  Fenton M, Rathbone J, Reilly J, Sultana A. Fenton M, et al. Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001944. doi: 10.1002/14651858.CD001944.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636691 Free PMC article. Review.

• Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data.

  Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF, Glasser DB, Morrison MF, Strom BL. Hennessy S, et al. BMJ. 2002 Nov 9;325(7372):1070. doi: 10.1136/bmj.325.7372.1070. BMJ. 2002. PMID: 12424166 Free PMC article.

• Cardiovascular adverse effects of antipsychotic drugs.

  Buckley NA, Sanders P. Buckley NA, et al. Drug Saf. 2000 Sep;23(3):215-28. doi: 10.2165/00002018-200023030-00004. Drug Saf. 2000. PMID: 11005704 Review.

• Drug-induced cardiovascular disorders.

  Murphy CA, Dargie HJ. Murphy CA, et al. Drug Saf. 2007;30(9):783-804. doi: 10.2165/00002018-200730090-00005. Drug Saf. 2007. PMID: 17722970 Review.

MeSH terms

Substances